Yaping Chu

Overview

Best Publications

• Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

  Jeffrey H Kordower;Yaping Chu;Robert A Hauser;Thomas B Freeman

  1945
  Citations

• Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

  Jeffrey H. Kordower;Marina E. Emborg;Jocelyne Bloch;Shuang Y. Ma

  1527
  Citations

• Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

  Jeffrey H. Kordower;C. Warren Olanow;Hemraj B. Dodiya;Yaping Chu

  1381
  Citations

• Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment.

  Jeffrey H. Kordower;Yaping Chu;Glenn T. Stebbins;Steven T. DeKosky

  550
  Citations

• Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

  Yaping Chu;Jeffrey H. Kordower

  483
  Citations

• Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.

  Yaping Chu;Hemraj Dodiya;Patrick Aebischer;C. Warren Olanow

  483
  Citations

• Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.

  Dwaine F. Emerich;Shelley R. Winn;Philippe M. Hantraye;Marc Peschanski

  379
  Citations

• Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease.

  Yaping Chu;Gerardo A. Morfini;Lori B. Langhamer;Yinzhen He

  355
  Citations

• Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins.

  William P. Flavin;Luc Bousset;Zachary C. Green;Yaping Chu

  322
  Citations

• Transplanted dopaminergic neurons develop PD pathologic changes: A second case report

  Jeffrey H. Kordower;Yaping Chu;Robert A. Hauser;C.Warren Olanow

  322
  Citations

• Nurr1 in Parkinson’s disease and related disorders

  Yaping Chu;Weidong Le;Katie Kompoliti;Joseph Jankovic

  308
  Citations

• Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra.

  Yaping Chu;Katie Kompoliti;Elizabeth J. Cochran;Elliott J. Mufson

  284
  Citations

• Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration

  Stephane Palfi;Stephane Palfi;Liza Leventhal;Yaping Chu;Shuang Y. Ma

  247
  Citations

• Lentiviral gene transfer to the nonhuman primate brain.

  Jeffrey H Kordower;Jocelyne Bloch;Shuang Y Ma;Yaping Chu

  240
  Citations

• A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.

  Michael S. Rafii;Tiffany L. Baumann;Roy A. E. Bakay;Jeffrey M. Ostrove

  240
  Citations

• Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration

  F. Cicchetti;S. Saporta;R. A. Hauser;M. Parent

  215
  Citations

• Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism

  Timothy J. Collier;Jack Lipton;Brian F. Daley;Stephane Palfi

  190
  Citations

• Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains

  Raymond T. Bartus;Christopher D. Herzog;Yaping Chu;Alistair Wilson

  188
  Citations

• Proteasome inhibition and Parkinson's disease modeling.

  Jordi Bové;Chun Zhou;Vernice Jackson-Lewis;Julie Taylor

  182
  Citations

• Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys.

  Jeffrey H. Kordower;Nicholas M. Kanaan;Yaping Chu;Rangasamy Suresh Babu

  171
  Citations